A group of undergraduate students at the University of Ottawa has developed 'Phytogene,' a method that enables plants to synthesize pharmaceutical drugs, starting with Ozempic. Using the tobacco cousin Nicotiana benthamiana, they aim to create a sustainable and cost-effective way to produce GLP-1 receptor agonists, which help with weight loss and blood sugar regulation. Inspired by the Ozempic shortage, the students' goal is to empower individuals to grow their medications at home, ensuring accessibility and reducing dependence on insurance and pharmaceutical costs. This innovation could reshape personal healthcare and expand drug availability.
Our goal is to enable individuals to cultivate their own health treatments at home, eliminating barriers related to cost and accessibility. This innovation is crucial for medical autonomy.
The breakthrough with Phytogene represents a shift towards personal medicine, where patients can leverage biotechnology to produce drugs like GLP-1 agonists, previously limited by insurance and cost constraints.
Collection
[
|
...
]